Arkolith/Insider Trading/DFFN/Form 4

Cobuzzi Robert Joseph Jr.

President & CEO, DirectorDiffusion Pharmaceuticals Inc. (DFFN) · full profile →Form 4 · filed May 3, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 2, 2022Disposed to issuer(D)121——998
May 2, 2022Option exercise(M)327——1K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 2, 2022Option exercise(M)327—$0981

Transaction Codes

D
Disposition to the issuer
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-22-010718) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML